ATR Stock Overview
Designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for ATR from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Injectables Expansion And Probiotics Demand Will Drive Future Success
AptarGroup, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$148.67 |
| 52 Week High | US$178.03 |
| 52 Week Low | US$135.96 |
| Beta | 0.59 |
| 1 Month Change | 1.87% |
| 3 Month Change | -4.39% |
| 1 Year Change | 4.88% |
| 3 Year Change | 23.89% |
| 5 Year Change | 38.59% |
| Change since IPO | 2,949.64% |
Recent News & Updates
Is AptarGroup (NYSE:ATR) Using Too Much Debt?
Mar 07
With EPS Growth And More, AptarGroup (NYSE:ATR) Makes An Interesting Case
Feb 21A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)
Feb 03Recent updates
Is AptarGroup (NYSE:ATR) Using Too Much Debt?
Mar 07With EPS Growth And More, AptarGroup (NYSE:ATR) Makes An Interesting Case
Feb 21A Look At The Fair Value Of AptarGroup, Inc. (NYSE:ATR)
Feb 03AptarGroup, Inc.'s (NYSE:ATR) Shares May Have Run Too Fast Too Soon
Jan 20AptarGroup (NYSE:ATR) Has Some Way To Go To Become A Multi-Bagger
Dec 25AptarGroup Has Gotten Too Expensive
Dec 02These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well
Nov 28Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Nov 14Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 46%?
Oct 28Risks To Shareholder Returns Are Elevated At These Prices For AptarGroup, Inc. (NYSE:ATR)
Oct 14Return Trends At AptarGroup (NYSE:ATR) Aren't Appealing
Sep 17
Proprietary Drug Delivery And Digital Health Innovations To Spearhead Revenue Surge
Aug 25 Expansion in digital health services and sustainability initiatives may enhance brand value and open up new market opportunities, driving future growth.Is AptarGroup (NYSE:ATR) A Risky Investment?
Aug 16AptarGroup, Inc. (NYSE:ATR) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Jul 31AptarGroup: Shares Are Pumped Up
Jul 16AptarGroup (NYSE:ATR) Has Announced That It Will Be Increasing Its Dividend To $0.45
Jul 15Here's Why We Think AptarGroup (NYSE:ATR) Is Well Worth Watching
Jul 02Getting In Cheap On AptarGroup, Inc. (NYSE:ATR) Is Unlikely
Jun 19Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)
Jun 05Here's Why Shareholders May Want To Be Cautious With Increasing AptarGroup, Inc.'s (NYSE:ATR) CEO Pay Packet
Apr 25AptarGroup: Exceptional Quality, But Priced For Perfection
Jan 18AptarGroup: The Market Price Has Run Ahead Of Its Performance
Oct 20AptarGroup: There Are Better Prospects Out There
Jul 29AptarGroup Non-GAAP EPS of $0.92 beats by $0.13, revenue of $795.91M beats by $20.34M
Feb 16Shareholder Returns
| ATR | US Packaging | US Market | |
|---|---|---|---|
| 7D | -0.5% | 1.1% | -0.9% |
| 1Y | 4.9% | 1.5% | 8.4% |
Return vs Industry: ATR exceeded the US Packaging industry which returned 1.5% over the past year.
Return vs Market: ATR underperformed the US Market which returned 8.4% over the past year.
Price Volatility
| ATR volatility | |
|---|---|
| ATR Average Weekly Movement | 3.3% |
| Packaging Industry Average Movement | 4.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ATR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ATR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 13,500 | Stephan Tanda | www.aptar.com |
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions.
AptarGroup, Inc. Fundamentals Summary
| ATR fundamental statistics | |
|---|---|
| Market cap | US$9.93b |
| Earnings (TTM) | US$374.54m |
| Revenue (TTM) | US$3.58b |
26.2x
P/E Ratio2.7x
P/S RatioIs ATR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ATR income statement (TTM) | |
|---|---|
| Revenue | US$3.58b |
| Cost of Revenue | US$2.23b |
| Gross Profit | US$1.36b |
| Other Expenses | US$980.97m |
| Earnings | US$374.54m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 01, 2025
| Earnings per share (EPS) | 5.68 |
| Gross Margin | 37.83% |
| Net Profit Margin | 10.45% |
| Debt/Equity Ratio | 40.3% |
How did ATR perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/03 23:36 |
| End of Day Share Price | 2025/04/03 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AptarGroup, Inc. is covered by 21 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ghansham Panjabi | Baird |
| Ishan Majumdar | Baptista Research |
| Mark Wilde | BMO Capital Markets Equity Research |